Clinical trials sponsored by Hanmi Pharmaceutical Company Limited

Phase breakdown

Conditions studied

Recruiting trials led by Hanmi Pharmaceutical Company Limited

• A Single and Multiple Ascending Dose Study of HM17321 in Healthy and Obese Participants
  NCT07219589 · Phase: Phase 1 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 1 location
• A Study to Evaluate Efficacy and Safety of HM11260C in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin and Dapagliflozin
  NCT07379333 · Phase: Phase 3 · Ages: 19 Years and older · Sex: All (male and female) · 1 location
• Belvarafenib in Combination With Cobimetinib in Patients With Locally Advanced or Metastatic NRAS-Mutant Melanoma
  NCT07449754 · Phase: Phase 2 · Ages: 19 Years and older · Sex: All (male and female) · 10 locations
• Effectiveness and Safety of Sequential Triple Combination Therapy (Amlodipine/Losartan/Chlorthalidone) in Korean Patients With Hypertension
  NCT07784296 · Phase: Not specified · Ages: No age limits stated · Sex: All (male and female) · 1 location
• Study to Evaluate HM15275 in Subjects With Type 2 Diabetes Mellitus
  NCT07527650 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 15 locations

Common questions

How many trials is Hanmi Pharmaceutical Company Limited recruiting for?

Hanmi Pharmaceutical Company Limited is the lead sponsor of 5 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.